514 related articles for article (PubMed ID: 16448918)
1. Chronic graft versus host disease of oral mucosa: review of available therapies.
Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
[TBL] [Abstract][Full Text] [Related]
2. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation.
Treister NS; Woo SB; O'Holleran EW; Lehmann LE; Parsons SK; Guinan EC
Biol Blood Marrow Transplant; 2005 Sep; 11(9):721-31. PubMed ID: 16125643
[TBL] [Abstract][Full Text] [Related]
3. Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patients.
Demarosi F; Lodi G; Carrassi A; Moneghini L; Sarina B; Sardella A
Exp Oncol; 2007 Dec; 29(4):304-8. PubMed ID: 18199988
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
5. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
6. Budesonide: a novel treatment for oral chronic graft versus host disease.
Elad S; Or R; Garfunkel AA; Shapira MY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
[TBL] [Abstract][Full Text] [Related]
7. Oral graft-versus-host disease.
Schubert MM; Correa ME
Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
[TBL] [Abstract][Full Text] [Related]
8. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
9. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
Epstein JB; Nantel S; Sheoltch SM
Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
[No Abstract] [Full Text] [Related]
11. Clinical utility of rituximab in chronic graft-versus-host disease.
Bates JS; Engemann AM; Hammond JM
Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
[TBL] [Abstract][Full Text] [Related]
12. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
[TBL] [Abstract][Full Text] [Related]
13. Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation.
Pereira CM; de Almeida OP; Corrêa ME; Costa FF; de Souza CA; Barjas-Castro ML
Oral Dis; 2007 May; 13(3):329-34. PubMed ID: 17448218
[TBL] [Abstract][Full Text] [Related]
14. How can we help patients with refractory chronic graft versus host disease- single centre experience.
Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C
Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
[TBL] [Abstract][Full Text] [Related]
16. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.
Wolff D; Gerbitz A; Ayuk F; Kiani A; Hildebrandt GC; Vogelsang GB; Elad S; Lawitschka A; Socie G; Pavletic SZ; Holler E; Greinix H
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1611-28. PubMed ID: 20601036
[TBL] [Abstract][Full Text] [Related]
17. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
da Fonseca MA; Hong C
Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573
[TBL] [Abstract][Full Text] [Related]
18. Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature.
Balasubramaniam R; Alawi F; DeRossi S
Gen Dent; 2009; 57(1):82-8. PubMed ID: 19146147
[TBL] [Abstract][Full Text] [Related]
19. Lichen sclerosus et atrophicus-like graft-versus-host disease post stem cell transplant.
Weinberg JL; Rosenbach M; Kim EJ; Kovarik CL
Dermatol Online J; 2009 Sep; 15(9):4. PubMed ID: 19930991
[TBL] [Abstract][Full Text] [Related]
20. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
